Skip to main navigation Skip to search Skip to main content

Dual signaling of the fas receptor: On Saudi patients with chronic Leukemia

  • Faris Q. Alenzi
  • , Fozah S.M. Alonizi
  • , Amani A. Ballow
  • , Meaad Q. Alanazi
  • , Dalal S. Al-Shaya
  • , Fahad G. Alanazi
  • , Omar Bagader
  • , Abdulrahman Q. Alanazi

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Purifed CD34+ cells and cultured colony forming unit-granulocyte and macrophage (CFU-GM) from human bone marrow were utilized to examine the role of Fas/FasL and caspase-8interactionsin the regulation of myelopoiesis. Methods: Fas and FasL expression in CD34+ cells and in day 14 CFU-GM were measured by RT-PCR and immunofluorescence in each case. The functional tests for the CFU-GM were the standard settlement test and the proliferative limit of CFU-GM was measured by replating the essential cells and monitoring auxiliary colony development. Results: Treatment of CFU-GM with IETD significantly increased, the proliferative limit, while the Fas mAb resulted in decreased the Fas and FasL expression were measuredutilizing RT-PCR and immunofluorescence individually. Conclusion: Fas, FasL, and caspase attenuationplay important rolesin the control of myelopoiesis.

Original languageEnglish
Pages (from-to)122-126
Number of pages5
JournalBangladesh Journal of Medical Science
Volume16
Issue number1
DOIs
StatePublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Dual signaling of the fas receptor: On Saudi patients with chronic Leukemia'. Together they form a unique fingerprint.

Cite this